Medlinker, a China-based social media platform for medical professionals backed by corporates Tencent and China Electronics Corporation Data, has raised RMB1bn ($146m) in series D capital, China Money Network reported today.
The round was led by industrial fund manager China Capital Zhongcai Fund and included venture capital firm Sequoia Capital, China Health Industry Investment Fund and Huaxing Capital, part of investment bank China Renaissance.
Founded in 2014, Medlinker runs a social media platform where verified physicians can share their expertise with colleagues, other healthcare providers, patients and pharmaceutical and insurance firms.
China Electronics Corporation Data, a subsidiary of computing technology producer China Electronics Corporation (CEC), led the company’s $60m series C round in December 2017.
The series C round also featured internet group Tencent, China Renaissance and Sequoia Capital China.
Tencent led Medlinker’s $40m series B round in September 2015 with participation from Yunfeng Capital, after Sequoia, Ceyuan Ventures and PreAngel had supplied a seven-figure dollar amount in a series A round earlier that year.